Keywords: Lung, Spectroscopy, Metabolomic imaging, acute respiratory distress syndrome, nuclear magnetic resonance, metabolomics, metabolites
Motivation: ARDS currently has unacceptable high mortality and long-term complications, which underscores the urgency of improving our understanding and management of ARDS.
Goal(s): To establish pathology-guided serum metabolomic profiles for ARDS patients by comparing them with profiles from patients without ARDS.
Approach: We measured ARDS serum using high-resolution magic angle spinning (HRMAS) magnetic resonance spectroscopy (MRS) to establish serum metabolomic profiles for ICU-patients with and without ARDS following various clinical outcomes.
Results: Serum specimens measured by HRMAS MRS enables the predictions of ARDS patient outcome in ICU.
Impact: Our initial results highlight the feasibility of HRMAS MRS in investigating ARDS metabolomic mechanisms, which may lay the basis for future diagnostic and therapeutic research, offering promising prospects for innovation in ARDS management.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords